WallStreetZenWallStreetZen

NASDAQ: GMAB
Genmab A Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for GMAB

Based on 4 analysts offering 12 month price targets for Genmab A.
Min Forecast
$32.00+12.04%
Avg Forecast
$45.00+57.56%
Max Forecast
$50.00+75.07%

Should I buy or sell GMAB stock?

Based on 4 analysts offering ratings for Genmab A.
Buy
Strong Buy
1 analysts 25%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
1 analysts 25%

Be the first to know when Wall Street analysts revise their GMAB stock forecasts and price targets.

GMAB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-04
lockedlocked$00.00+00.00%2024-03-26
lockedlocked$00.00+00.00%2024-03-26
lockedlocked$00.00+00.00%2024-02-23

1 of 1

Forecast return on equity

Is GMAB forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.5%

Forecast return on assets

Is GMAB forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

GMAB revenue forecast

What is GMAB's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$2.8B+15.03%
Avg 2 year Forecast
$3.4B+40.58%
Avg 3 year Forecast
$4.4B+81.22%
GMAB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GMAB earnings growth forecast

How is GMAB forecast to perform vs Biotechnology companies and vs the US market?
Company
48.09%
Industry
7.27%
Market
21.77%
GMAB's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
GMAB's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
GMAB's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

GMAB revenue growth forecast

How is GMAB forecast to perform vs Biotechnology companies and vs the US market?
Company
21.76%
Industry
37.57%
Market
10.16%
GMAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GMAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GMAB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GMAB$28.56$45.00+57.56%Buy
ALNY$146.07$213.58+46.22%Buy
BMRN$92.06$103.44+12.37%Strong Buy
BNTX$88.49$114.71+29.63%Hold
RPRX$27.82$46.75+68.04%Strong Buy
View Top Biotech Stocks

Genmab A Stock Forecast FAQ

Is Genmab A Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: GMAB) stock is to Buy GMAB stock.

Out of 4 analysts, 1 (25%) are recommending GMAB as a Strong Buy, 2 (50%) are recommending GMAB as a Buy, 0 (0%) are recommending GMAB as a Hold, 0 (0%) are recommending GMAB as a Sell, and 1 (25%) are recommending GMAB as a Strong Sell.

If you're new to stock investing, here's how to buy Genmab A stock.

What is GMAB's revenue growth forecast for 2024-2026?

(NASDAQ: GMAB) Genmab A's forecast annual revenue growth rate of 21.76% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.57%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.16%.

Genmab A's revenue in 2024 is $2,397,962,154.On average, 6 Wall Street analysts forecast GMAB's revenue for 2024 to be $185,505,446,354, with the lowest GMAB revenue forecast at $180,192,525,144, and the highest GMAB revenue forecast at $187,606,748,716. On average, 5 Wall Street analysts forecast GMAB's revenue for 2025 to be $226,694,989,982, with the lowest GMAB revenue forecast at $218,398,142,772, and the highest GMAB revenue forecast at $240,122,128,389.

In 2026, GMAB is forecast to generate $292,241,259,075 in revenue, with the lowest revenue forecast at $267,767,713,833 and the highest revenue forecast at $337,131,439,185.

What is GMAB's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: GMAB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is GMAB's Price Target?

According to 4 Wall Street analysts that have issued a 1 year GMAB price target, the average GMAB price target is $45.00, with the highest GMAB stock price forecast at $50.00 and the lowest GMAB stock price forecast at $32.00.

On average, Wall Street analysts predict that Genmab A's share price could reach $45.00 by Apr 4, 2025. The average Genmab A stock price prediction forecasts a potential upside of 57.56% from the current GMAB share price of $28.56.

What is GMAB's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: GMAB) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.